Arca
Skip to content
Tools
Tools

Irregular Rhythm Notification Feature

Photoplethysmograph Analysis Software For Over-The-Counter Use. De Novo DEN180042, from Apple, Inc. (Alexandria, VA). Product code QDB, class 2.

As of Nov 19, 2026, DEN180042 is an FDA De Novo held by Apple, Inc., granted on Sep 11, 2018 after 33 days, with no recalls tied to it in FDA's recall database.

  • Review time: 33 days
  • Recalls: 0
  • Cited as a predicate by: 4 devices

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The Irregular Rhythm Notification Feature is a software-only mobile medical application that is intended to be used with the Apple Watch. The feature analyzes pulse rate data to identify episodes of irregular heart rhythms suggestive of atrial fibrillation (AFib) and provides a notification to the user. The feature is intended for

Pivotal study

The main clinical evidence FDA relied on, as its decision summary describes it
Design
Prospective, single-arm sub-study of participants with one prior notification; PPV vs. 7-day ambulatory ECG patch
Enrolled
269
Primary endpoint
PPV of spot irregular tachograms to detect AF vs. ambulatory ECG patch monitoring reference, vs. pre-specified performance goal
Result
Not met: PPV 66.6% (lower 97.5% confidence bound 63.0%) failed pre-specified performance goal

Cited as a predicate

4 later 510(k) summaries name this device as a predicate

Other QDB clearances

The newest 510(k)s for the same product code; their median review was 165 days; see every QDB device

Record

Type
Direct
Received
Aug 9, 2018
Review panel
Cardiovascular
Regulation
21 CFR 870.2790

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.